↓ Skip to main content

Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors

Overview of attention for article published in Frontiers in oncology, October 2020
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter
7 X users

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors
Published in
Frontiers in oncology, October 2020
DOI 10.3389/fonc.2020.576314
Pubmed ID
Authors

Karam Khaddour, Sandra L. Gomez-Perez, Nikita Jain, Jyoti D. Patel, Yanis Boumber

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 17%
Student > Bachelor 4 11%
Student > Doctoral Student 2 6%
Student > Postgraduate 2 6%
Student > Master 1 3%
Other 1 3%
Unknown 20 56%
Readers by discipline Count As %
Medicine and Dentistry 13 36%
Biochemistry, Genetics and Molecular Biology 2 6%
Immunology and Microbiology 1 3%
Psychology 1 3%
Unknown 19 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 August 2021.
All research outputs
#6,448,566
of 25,387,668 outputs
Outputs from Frontiers in oncology
#2,101
of 22,433 outputs
Outputs of similar age
#134,076
of 439,040 outputs
Outputs of similar age from Frontiers in oncology
#74
of 692 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 22,433 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,040 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 692 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.